Literature DB >> 2467353

The MRL-lpr/lpr mouse. A model for the study of rheumatoid arthritis.

W J Koopman1, S Gay.   

Abstract

Autoimmune MRL-lpr/lpr mice develop a spontaneous destructive arthropathy sharing some features with rheumatoid arthritis including synovial cell proliferation, pannus formation, rheumatoid nodule-like lesions and circulating rheumatoid factors. Rheumatoid factors elaborated by MRL-lpr/lpr mice exhibit binding characteristics similar to those found in the sera of patients with rheumatoid arthritis; however, these autoantibodies do not appear to be essential for the induction of arthritis in MRL-lpr/lpr mice. Molecular studies, indicating that VH genes from several VH families are capable of encoding these rheumatoid factors, argue against the existence of unique "autoantibody genes" in the germline of MRL-lpr/lpr mice. Although the mechanisms underlying cartilage injury in MRL-lpr/lpr mice have not been elucidated, available evidence suggests that invading synovial cells play an important role. Delineation of the cellular and molecular mechanisms responsible for articular destruction in MRL-lpr/lpr mice may provide important insights concerning the pathogenesis of rheumatoid arthritis.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2467353     DOI: 10.3109/03009748809096780

Source DB:  PubMed          Journal:  Scand J Rheumatol Suppl        ISSN: 0301-3847


  9 in total

Review 1.  Rheumatoid arthritis: a synovial disease?

Authors:  K Fujii; M Tsuji; M Tajima
Journal:  Ann Rheum Dis       Date:  1999-12       Impact factor: 19.103

Review 2.  Use of localised gene transfer to develop new treatment strategies for the salivary component of Sjögren's syndrome.

Authors:  M R Kok; B J Baum; P P Tak; S R Pillemer
Journal:  Ann Rheum Dis       Date:  2003-11       Impact factor: 19.103

Review 3.  Molecular and cellular mechanisms of joint destruction in rheumatoid arthritis: two cellular mechanisms explain joint destruction?

Authors:  S Gay; R E Gay; W J Koopman
Journal:  Ann Rheum Dis       Date:  1993-03       Impact factor: 19.103

Review 4.  Retroviruses and autoimmune rheumatic diseases.

Authors:  J R Kalden; S Gay
Journal:  Clin Exp Immunol       Date:  1994-10       Impact factor: 4.330

Review 5.  How the study of children with rheumatic diseases identified interferon-alpha and interleukin-1 as novel therapeutic targets.

Authors:  Virginia Pascual; Florence Allantaz; Pinakeen Patel; A Karolina Palucka; Damien Chaussabel; Jacques Banchereau
Journal:  Immunol Rev       Date:  2008-06       Impact factor: 12.988

6.  Identification of a common lupus disease-associated microRNA expression pattern in three different murine models of lupus.

Authors:  Rujuan Dai; Yan Zhang; Deena Khan; Bettina Heid; David Caudell; Oswald Crasta; S Ansar Ahmed
Journal:  PLoS One       Date:  2010-12-10       Impact factor: 3.240

7.  Similar dysregulation of lupus-associated miRNAs in peripheral blood mononuclear cells and splenic lymphocytes in MRL/lpr mice.

Authors:  Zhuang Wang; Bettina Heid; Rujuan Dai; Sattar Ansar Ahmed
Journal:  Lupus Sci Med       Date:  2018-11-05

8.  Galectin-9 ameliorates clinical severity of MRL/lpr lupus-prone mice by inducing plasma cell apoptosis independently of Tim-3.

Authors:  Masahiro Moritoki; Takeshi Kadowaki; Toshiro Niki; Daisuke Nakano; Genichiro Soma; Hirohito Mori; Hideki Kobara; Tsutomu Masaki; Masakazu Kohno; Mitsuomi Hirashima
Journal:  PLoS One       Date:  2013-04-09       Impact factor: 3.240

Review 9.  Autoantibodies in rheumatoid arthritis and their clinical significance.

Authors:  Günter Steiner; Josef Smolen
Journal:  Arthritis Res       Date:  2002-04-26
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.